Management of periocular actinic keratosis: a review of practice patterns among ophthalmic plastic surgeons.
Abstract
[PURPOSE] To determine the practice patterns of ophthalmic plastic surgeons regarding the management of actinic keratosis (AK) of the eyelid and periocular area.
[METHODS] A brief electronic survey was distributed to members of the American Society of Ophthalmic Plastic and Reconstructive Surgery requesting their demographic information and treatment approaches to AK.
[RESULTS] One hundred and seven of 523 (20.5%) American Society of Ophthalmic Plastic and Reconstructive Surgery members completed the survey. Most respondents treat AK < 2 mm from the eyelid margin by excision with permanent pathology (62.6%), followed by referral for Mohs excision (10.3%) and excision with frozen section control (9.3%). Similar responses were recorded for the treatment of AK > 2 mm from the eyelid margin, with most respondents treating by excision with permanent pathology (56.1%), followed by referral to dermatology for Mohs or non-Mohs treatment and topical chemotherapy (8.4% each).
[CONCLUSION] Although most American Society of Ophthalmic Plastic and Reconstructive Surgery members use excisional biopsy with permanent section pathology control of margins for the treatment of AK of the eyelid and periocular region, multiple alternative treatment approaches are also used.
[METHODS] A brief electronic survey was distributed to members of the American Society of Ophthalmic Plastic and Reconstructive Surgery requesting their demographic information and treatment approaches to AK.
[RESULTS] One hundred and seven of 523 (20.5%) American Society of Ophthalmic Plastic and Reconstructive Surgery members completed the survey. Most respondents treat AK < 2 mm from the eyelid margin by excision with permanent pathology (62.6%), followed by referral for Mohs excision (10.3%) and excision with frozen section control (9.3%). Similar responses were recorded for the treatment of AK > 2 mm from the eyelid margin, with most respondents treating by excision with permanent pathology (56.1%), followed by referral to dermatology for Mohs or non-Mohs treatment and topical chemotherapy (8.4% each).
[CONCLUSION] Although most American Society of Ophthalmic Plastic and Reconstructive Surgery members use excisional biopsy with permanent section pathology control of margins for the treatment of AK of the eyelid and periocular region, multiple alternative treatment approaches are also used.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | eyelid
|
눈꺼풀 | dict | 4 | |
| 해부 | periocular
|
scispacy | 1 | ||
| 합병증 | periocular actinic
|
scispacy | 1 | ||
| 합병증 | actinic keratosis
|
scispacy | 1 | ||
| 합병증 | periocular area
|
scispacy | 1 | ||
| 합병증 | eyelid margin
|
scispacy | 1 | ||
| 합병증 | excisional biopsy
|
scispacy | 1 | ||
| 약물 | [RESULTS] One
|
scispacy | 1 | ||
| 질환 | periocular actinic keratosis
|
scispacy | 1 | ||
| 질환 | actinic keratosis
|
C0022602
Actinic keratosis
|
scispacy | 1 | |
| 기타 | AK > 2
|
scispacy | 1 |
MeSH Terms
Dermatology; Eyelid Diseases; Health Surveys; Humans; Keratosis, Actinic; Mohs Surgery; Ophthalmologic Surgical Procedures; Ophthalmology; Orbital Diseases; Practice Patterns, Physicians'; Referral and Consultation; Societies, Medical; Surgery, Plastic; United States
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Application of the SCIA-Pure Skin Perforator Flap in Bilateral Upper Eyelid Reconstruction: A Case Report and Review of the Literature.
- Combined minimally invasive lymphatic microsurgery and aligned nanofibrillar collagen scaffold for refractory post-traumatic eyelid lymphedema: A case report.
- Orbicularis Oculi Toxin Injection for Treating Levator Palpebrae Superioris Weakness: Clinical Effect and Safety in a Cohort Study.
- Correction of tear trough deformity in young patients without eyebags using orbital fat reposition and release of tear trough ligament.